Our next summit will take place on October 24-26, 2017
in Washington, DC.
Wrapping up its eighth year, CHI’s Immunogenicity and Bioassay Summit 2016 was host to 250+ industry, academia and regulatory authorities who shared new ways of overcoming immunogenicity and bioassay challenges at 3 co-located conferences and 4 short courses. Cambridge Healthtech Institute (CHI) would like to thank all the speakers, attendees, sponsors, and exhibitors for their participation.
2016 Event Stats:
- 250+ Delegates from 145 Companies
- 60 Speakers
- 25 Posters Presented
- 15 Countries Represented
- 14 Exhibiting Companies
View the 2016 Attendee List
Here’s what one of our delegate’s on-site said:
“CHI's Optimizing Bioassay for Biologics is one of the best bioassay venues in the biotech and biopharma industry. The conference provides very deep and broad scientific presentations, roundtable discussions, and excellent network opportunities for scientists, managers/directors, CROs, vendors and consultants.”
- Senior Group
Leader, Bioassay Development, Hospira, a Pfizer Company
If you missed our 2016 event, you can reserve a copy of the conference proceedings CD to access the speakers’ slides and poster abstracts our delegates received on-site.
SAVE THE DATE: CHI’s Ninth Annual Immunogenicity and Bioassay Summit 2017 will be held on October 24-26, 2017 at the Westin Alexandria in Washington, DC.
We are currently recruiting speakers for the 2017 summit. If you are interested in speaking, please contact Nicole Lyscom, Ph.D. at firstname.lastname@example.org.
To secure a sponsorship or exhibit package for 2017, contact Carolyn Benton at email@example.com.
Bookmark our website to stay tuned for details on the 2017 event.